Clinical Trial Update: A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sirolimus with standard therapy in kidney transplant patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Boston Children's Hospital | Conditions: End-Stage Renal Disease, Kidney Transplantation | Phase 3 | Status: TERMINATED